AstraZeneca (AZN): Q3 core EPS of $1.71 beats by $0.01. Revenue of $8.21B (+4% Y/Y) beats by...

|About: AstraZeneca Group plc (AZN)|By:, SA News Editor
AstraZeneca (AZN): Q3 core EPS of $1.71 beats by $0.01. Revenue of $8.21B (+4% Y/Y) beats by $50M. Net profit +124% to $3.48B, in line. Raises FY core EPS forecast to $7.20-$7.40 from $7.05-$7.35. Earnings benefited from favorable currency movements, sale of dental unit, and strong performances in emerging markets. (PR)